PiùMedical (PMED) Stock Overview

Owns and operates a retail pharmaceutical chain in Lombardy region in Italy. More details

PMED fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Shares are highly illiquid

Does not have a meaningful market cap (€37M)

PMED Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

PiùMedical S.p.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for PiùMedical
Historical stock prices
Current Share Price	€5.81
52 Week High	€6.20
52 Week Low	€5.70
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-3.23%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	PMED	IT Consumer Retailing	IT Market
7D	n/a	-2.5%	-3.3%
1Y	n/a	6.1%	27.4%

Return vs Industry: Insufficient data to determine how PMED performed against the Italian Consumer Retailing industry.

Return vs Market: Insufficient data to determine how PMED performed against the Italian Market.

Price Volatility

Is PMED's price volatile compared to industry and market?
PMED volatility
PMED Average Weekly Movement	n/a
Consumer Retailing Industry Average Movement	3.8%
Market Average Movement	4.3%
10% most volatile stocks in IT Market	7.5%
10% least volatile stocks in IT Market	2.5%

Stable Share Price: PMED's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine PMED's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2016	n/a	Stefano Maroni	www.piumedical.com

PiùMedical S.p.A. owns and operates a retail pharmaceutical chain in Lombardy region in Italy. The company manages a network of sixteen pharmacies and engages in the management and development of community pharmacies through a centralized operating model. It offers a consolidation platform with a buy-fix-scale model active in the retail pharmacy sector.

PiùMedical S.p.A. Fundamentals Summary

How do PiùMedical's earnings and revenue compare to its market cap?
PMED fundamental statistics
Market cap	€36.87m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is PMED overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PMED income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PMED perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/20 06:29
End of Day Share Price	2025/11/20 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PiùMedical S.p.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.